Russell Investments Group, Ltd. Lexicon Pharmaceuticals, Inc. Transaction History

Russell Investments Group, Ltd.

$66.8 Billion
Q3 2024

A detailed history of Russell Investments Group, Ltd. transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 49,100 shares of LXRX stock, worth $40,753. This represents 0.0% of its overall portfolio holdings.

Number of Shares

49,100

Previous 53,080 7.5%

Holding current value

$40,753

Previous $89,000 13.48%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$1.51 - $2.39 $6,009 - $9,512	-3,980 Reduced 7.5%	49,100 $77,000
Q2 2024 Aug 08, 2024	BUY	$1.54 - $2.28 $6,129 - $9,074	3,980 Added 8.11%	53,080 $89,000
Q3 2023 Nov 13, 2023	SELL	$1.06 - $2.33 $6,600 - $14,508	-6,227 Reduced 11.25%	49,100 $53,000
Q1 2023 May 09, 2023	SELL	$1.99 - $2.68 $384,243 - $517,473	-193,087 Reduced 77.73%	55,327 $134,000
Q3 2022 Nov 04, 2022	SELL	$1.94 - $3.43 $3,691 - $6,527	-1,903 Reduced 0.76%	248,414 $595,000
Q4 2021 Jan 21, 2022	BUY	$3.81 - $6.16 $30,975 - $50,080	8,130 Added 3.36%	250,317 $985,000
Q1 2021 May 10, 2021	BUY	$3.45 - $9.09 $169,395 - $446,319	49,100 Added 25.43%	242,187 $1.42 Million
Q4 2020 Feb 08, 2021	SELL	$1.05 - $3.67 $316,515 - $1.11 Million	-301,443 Reduced 60.96%	193,087 $660,000
Q3 2020 Nov 09, 2020	BUY	$1.44 - $2.1 $707,942 - $1.03 Million	491,627 Added 16935.14%	494,530 $712,000
Q2 2020 Aug 05, 2020	SELL	$1.75 - $2.3 $15,071 - $19,807	-8,612 Reduced 74.79%	2,903 $5,000
Q1 2020 May 06, 2020	BUY	$1.8 - $4.28 $20,727 - $49,284	11,515 New	11,515 $22,000
Q4 2019 Jan 29, 2020	SELL	$3.16 - $5.15 $212,984 - $347,110	-67,400 Closed	0 $0
Q3 2019 Nov 01, 2019	BUY	$1.2 - $6.66 $80,880 - $448,884	67,400 New	67,400 $202,000
Q2 2019 Aug 09, 2019	SELL	$5.35 - $7.11 $52,430 - $69,678	-9,800 Closed	0 $0
Q1 2019 May 13, 2019	SELL	$4.36 - $7.94 $34,444 - $62,726	-7,900 Reduced 44.63%	9,800 $55,000
Q4 2018 Feb 11, 2019	BUY	$6.15 - $10.51 $108,855 - $186,027	17,700 New	17,700 $117,000
Q4 2017 Feb 06, 2018	SELL	$8.77 - $12.28 $590,203 - $826,419	-67,298 Closed	0 $0
Q3 2017 Nov 07, 2017	BUY	$12.17 - $16.3 $819,016 - $1.1 Million	67,298	67,298 $827,000

Others Institutions Holding LXRX

# of Institutions

141

Shares Held

238M

Call Options Held

459K

Put Options Held

133K

View Full List

About LEXICON PHARMACEUTICALS, INC.

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $157M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

More about LXRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.

Account

Russell Investments Group, Ltd. Lexicon Pharmaceuticals, Inc. Transaction History